Circulating IGF-I independently predicts blood pressure in children with higher calcium-phosphorus product levels.
To study the association between IGF-I and blood pressure in children, in particular, the potential interaction with the serum calcium-phosphorus product (Ca*P) in this association. In a longitudinal study, 521 children (age 8.8 ± 0.1) from North-Eastern Spain were studied, of whom 158 were followed-up after 5 years. IGF-I, IGFBP-3, serum calcium and phosphorus were measured at baseline. Anthropometric [body-mass index (BMI) and waist] and cardio-metabolic [systolic (SBP) and diastolic blood pressure, pulse pressure, insulin, homeostatic model assessment of insulin resistance (HOMA-IR), HDL cholesterol and triglycerides] variables were assessed at baseline and at the end of follow-up. Statistical analysis included Pearson correlations followed by multivariable linear regression analyses. Baseline IGF-I and IGF-I/IGFBP-3 molar ratio positively correlated with baseline and follow-up BMI, waist, SBP, pulse pressure, insulin, HOMA-IR and triglycerides (r from 0.138 to 0.603; all p<0.05). The associations with SBP were stronger with increasing Ca*P (r from 0.261 to 0.625 for IGF-I; and r from 0.174 to 0.583 for IGF-I/IGFBP-3). After adjusting for confounding variables, baseline IGF-I and IGF-I/IGFBP-3 remained independently associated with both baseline and follow-up SBP in children in the highest Ca*P tertile (β from 0.245 to 0.381; p<0.01; model R2 from 0.246 to 0.566). Our results suggest that IGF-I in childhood is an independent predictor of SBP in apparently healthy children, especially in those with high Ca*P levels.